New! Sign up for our free email newsletter.
Science News
from research organizations

Pathway of Alzheimer's degeneration discovered

Finding is key for future treatment and earlier diagnosis

Date:
July 5, 2018
Source:
McGill University
Summary:
Scientists have used a unique approach to track brain degeneration in Alzheimer's disease, uncovering a pathway through which degeneration spreads from one region to another.
Share:
FULL STORY

Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of McGill University have used a unique approach to track brain degeneration in Alzheimer's disease, uncovering a pathway through which degeneration spreads from one region to another.

Individuals in the early stages of Alzheimer's disease (AD) were scanned using both structural magnetic resonance imaging (sMRI) and positron emission tomography (PET). The scientists were interested in how AD affects the basal forebrain -- a deep brain structure that supplies the outer cortex with acetylcholine, a neurotransmitter that is critical for maintaining normal brain function. They found that as cholinergic neurons in the basal forebrain degenerate, the areas in the cortex which receive their cholinergic inputs also degenerate.

Based on post-mortem examinations of brain tissue, it has been known for quite some time that the cholinergic neurons are particularly vulnerable to degeneration in Alzheimer's disease. However, this study is among the first in which scientists were able to track degeneration of cholinergic neurons in living humans. "A key finding from this study is that the results from sMRI scans matched what we were seeing on PET scans, despite the fact they provide different types of measurements and were performed on different patients" said Dr. Nathan Spreng, Director of the Laboratory of Brain and Cognition at The Neuro. "The combination of PET with sMRI may therefore represent be a powerful tool for tracking the progression of Alzheimer's disease in living patients."

"This study shows PET and sMRI scans could potentially be used to diagnose Alzheimer's disease before cognitive symptoms appear, giving doctors a better window of time to work on prevention," said Taylor Schmitz, researcher in Dr. Spreng's lab and the study's lead author. "Drugs that promote the delivery of acetylcholine to these cortical regions could be one way to prevent degeneration."

The results of this study were published in the journal Cell Reports on July 3, 2018. Schmitz says that he would like to follow up with a larger study of patients in earlier stages of the disease, and perform structural MRI and PET on the same patients to confirm the previous study's results.


Story Source:

Materials provided by McGill University. Note: Content may be edited for style and length.


Cite This Page:

McGill University. "Pathway of Alzheimer's degeneration discovered." ScienceDaily. ScienceDaily, 5 July 2018. <www.sciencedaily.com/releases/2018/07/180705110045.htm>.
McGill University. (2018, July 5). Pathway of Alzheimer's degeneration discovered. ScienceDaily. Retrieved April 19, 2024 from www.sciencedaily.com/releases/2018/07/180705110045.htm
McGill University. "Pathway of Alzheimer's degeneration discovered." ScienceDaily. www.sciencedaily.com/releases/2018/07/180705110045.htm (accessed April 19, 2024).

Explore More

from ScienceDaily

RELATED STORIES